256 related articles for article (PubMed ID: 14629128)
1. Low-cost CD4 enumeration in HIV-infected patients in Thailand.
Pattanapanyasat K; Lerdwana S; Shain H; Noulsri E; Thepthai C; Prasertsilpa V; Eksaengsri A; Kraisintu K
Asian Pac J Allergy Immunol; 2003 Jun; 21(2):105-13. PubMed ID: 14629128
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a new single-parameter volumetric flow cytometer (CyFlow(green)) for enumeration of absolute CD4+ T lymphocytes in human immunodeficiency virus type 1-infected Thai patients.
Pattanapanyasat K; Lerdwana S; Noulsri E; Chaowanachan T; Wasinrapee P; Sakulploy N; Pobkeeree V; Suksripanich O; Thanprasertsuk S; Spira TJ; Tappero JW; Levine WC
Clin Diagn Lab Immunol; 2005 Dec; 12(12):1416-24. PubMed ID: 16339065
[TBL] [Abstract][Full Text] [Related]
3. Affordable CD4(+)-T-cell counting by flow cytometry: CD45 gating for volumetric analysis.
Janossy G; Jani IV; Bradley NJ; Bikoue A; Pitfield T; Glencross DK
Clin Diagn Lab Immunol; 2002 Sep; 9(5):1085-94. PubMed ID: 12204964
[TBL] [Abstract][Full Text] [Related]
4. Affordable flow cytometry for enumeration of absolute CD4+ T-lymphocytes to identify subtype C HIV-1 infected adults requiring antiretroviral therapy (ART) and monitoring response to ART in a resource-limited setting.
Zijenah LS; Kadzirange G; Madzime S; Borok M; Mudiwa C; Tobaiwa O; Mucheche M; Rusakaniko S; Katzenstein DA
J Transl Med; 2006 Aug; 4():33. PubMed ID: 16907973
[TBL] [Abstract][Full Text] [Related]
5. Low-cost assays for monitoring HIV infected individuals in resource-limited settings.
Balakrishnan P; Iqbal HS; Shanmugham S; Mohanakrishnan J; Solomon SS; Mayer KH; Solomon S
Indian J Med Res; 2011 Dec; 134(6):823-34. PubMed ID: 22310816
[TBL] [Abstract][Full Text] [Related]
6. Assessment of two POC technologies for CD4 count in Morocco.
Elharti E; Abbadi H; Bensghir R; Marhoum El Filali K; Elmrabet H; Oumzil H
AIDS Res Ther; 2020 Jun; 17(1):31. PubMed ID: 32522235
[TBL] [Abstract][Full Text] [Related]
7. A microfluidic device for practical label-free CD4(+) T cell counting of HIV-infected subjects.
Cheng X; Irimia D; Dixon M; Sekine K; Demirci U; Zamir L; Tompkins RG; Rodriguez W; Toner M
Lab Chip; 2007 Feb; 7(2):170-8. PubMed ID: 17268618
[TBL] [Abstract][Full Text] [Related]
8. Clinical Evaluation of the BD FACSPresto™ Near-Patient CD4 Counter in Kenya.
Angira F; Akoth B; Omolo P; Opollo V; Bornheimer S; Judge K; Tilahun H; Lu B; Omana-Zapata I; Zeh C
PLoS One; 2016; 11(8):e0157939. PubMed ID: 27483008
[TBL] [Abstract][Full Text] [Related]
9. Accurate and reproducible enumeration of CD4 T cell counts and Hemoglobin levels using a point of care system: Comparison with conventional laboratory based testing systems in a clinical reference laboratory in Cameroon.
Sagnia B; Mbakop Ghomsi F; Moudourou S; Gutierez A; Tchadji J; Sosso SM; Ndjolo A; Colizzi V
PLoS One; 2024; 19(3):e0297790. PubMed ID: 38507344
[TBL] [Abstract][Full Text] [Related]
10. CD4 immunophenotyping in HIV infection.
Barnett D; Walker B; Landay A; Denny TN
Nat Rev Microbiol; 2008 Nov; 6(11 Suppl):S7-15. PubMed ID: 18923413
[TBL] [Abstract][Full Text] [Related]
11. T-cell enumeration from dried blood spots by quantifying rearranged T-cell receptor-beta genes.
Redd AD; Ciccone EJ; Nakigozi G; Keruly JC; Ndyanabo A; Iga B; Gray RH; Serwadda D; Quinn TC
J Immunol Methods; 2010 Mar; 354(1-2):40-4. PubMed ID: 20109463
[TBL] [Abstract][Full Text] [Related]
12. Absolute CD4 count and percentage values among Libyan patients with HIV by single-platform flow cytometry.
Lamami Y; Abulayha AM; Altabal S; Elbasir M; Elbnnani AS; Aghil L; Ebrahim F; Elzagheid A
Lab Med; 2024 Jun; ():. PubMed ID: 38902933
[TBL] [Abstract][Full Text] [Related]
13. Performance Evaluation of Microscanner Plus, an Automated Image-Based Cell Counter, for Counting CD4+ T Lymphocytes in HIV Patients.
Jang WS; Lee J; Park S; Lim CS; Kim J
Diagnostics (Basel); 2023 Dec; 14(1):. PubMed ID: 38201382
[TBL] [Abstract][Full Text] [Related]
14. Integration of semiconductor quantum dots into nano-bio-chip systems for enumeration of CD4+ T cell counts at the point-of-need.
Jokerst JV; Floriano PN; Christodoulides N; Simmons GW; McDevitt JT
Lab Chip; 2008 Dec; 8(12):2079-90. PubMed ID: 19023471
[TBL] [Abstract][Full Text] [Related]
15. A Brief Chronicle of CD4 as a Biomarker for HIV/AIDS: A Tribute to the Memory of John L. Fahey.
Kagan JM; Sanchez AM; Landay A; Denny TN
For Immunopathol Dis Therap; 2015; 6(1-2):55-64. PubMed ID: 27182452
[TBL] [Abstract][Full Text] [Related]
16. Towards a Point-of-Care Test of CD4
Leuthner M; Reisbeck M; Helou M; Hayden O
Micromachines (Basel); 2024 Apr; 15(4):. PubMed ID: 38675331
[TBL] [Abstract][Full Text] [Related]
17. DNA framework signal amplification platform-based high-throughput systemic immune monitoring.
Chen Y; Chen X; Zhang B; Zhang Y; Li S; Liu Z; Gao Y; Zhao Y; Yan L; Li Y; Tian T; Lin Y
Signal Transduct Target Ther; 2024 Feb; 9(1):28. PubMed ID: 38320992
[TBL] [Abstract][Full Text] [Related]
18. Vitiligo: is it grace or curse?
Bakry OA; Hammam MA; Abdel Wahed MM
Acta Dermatovenerol Croat; 2013; 21(2):71-9. PubMed ID: 24001413
[TBL] [Abstract][Full Text] [Related]
19. "Combined" desmoplastic melanoma of the vulva with poor clinical outcome.
Collina G
Pathologica; 2011 Dec; 103(6):337-9. PubMed ID: 22558891
[TBL] [Abstract][Full Text] [Related]
20. Vemurafenib (PLX4032): an orally available inhibitor of mutated BRAF for the treatment of metastatic melanoma.
Heakal Y; Kester M; Savage S
Ann Pharmacother; 2011 Nov; 45(11):1399-405. PubMed ID: 22028422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
